Success Metrics

Clinical Success Rate
90.5%

Based on 76 completed trials

Completion Rate
90%(76/84)
Active Trials
16(11%)
Results Posted
8%(6 trials)
Terminated
8(6%)

Phase Distribution

Ph phase_4
42
29%
Ph phase_1
5
3%
Ph early_phase_1
6
4%
Ph phase_2
10
7%
Ph not_applicable
55
38%
Ph phase_3
18
12%

Phase Distribution

11

Early Stage

10

Mid Stage

60

Late Stage

Phase Distribution136 total trials
Early Phase 1First-in-human
6(4.4%)
Phase 1Safety & dosage
5(3.7%)
Phase 2Efficacy & side effects
10(7.4%)
Phase 3Large-scale testing
18(13.2%)
Phase 4Post-market surveillance
42(30.9%)
N/ANon-phased studies
55(40.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

86.4%

76 of 88 finished

Non-Completion Rate

13.6%

12 ended early

Currently Active

16

trials recruiting

Total Trials

145

all time

Status Distribution
Active(25)
Completed(76)
Terminated(12)
Other(32)

Detailed Status

Completed76
unknown28
Recruiting12
Terminated8
Not yet recruiting7
Suspended4

Development Timeline

Analytics

Development Status

Total Trials
145
Active
16
Success Rate
90.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 16 (4.4%)
Phase 15 (3.7%)
Phase 210 (7.4%)
Phase 318 (13.2%)
Phase 442 (30.9%)
N/A55 (40.4%)

Trials by Status

completed7652%
not_yet_recruiting75%
terminated86%
enrolling_by_invitation21%
suspended43%
active_not_recruiting43%
unknown2819%
withdrawn43%
recruiting128%

Recent Activity

Clinical Trials (145)

Showing 20 of 145 trialsScroll for more
NCT04592744Phase 4

Angiotensin 2 for AKI After OLT

Active Not Recruiting
NCT05193968Not Applicable

Hot Flashes and Neurovascular Function in Women

Recruiting
NCT06746753Phase 4

Mechanistic Assessment of Norepinephrine Therapy vs. Angiotensin-II in Septic Shock

Not Yet Recruiting
NCT07627360Not Applicable

PRO STRESS Trial: Proactive Low-Dose Norepinephrine to Reduce Intraoperative Fluid Administration in Patients at High-Risk for Postoperative Pulmonary Complications Undergoing Laparoscopic Abdominal Surgery

Not Yet Recruiting
NCT07614438Phase 2

Effect of Vasopressin Versus Norepinephrine on Post-operative Mean Pulmonary Arterial Pressure Following Pulmonary Endarterectomy Surgery,

Not Yet Recruiting
NCT06802224Phase 4

The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery

Recruiting
NCT04777383Not Applicable

The Effects of Iontophoresed Vasoactive Drugs on Cutaneus Blood Flow

Terminated
NCT07562932Not Applicable

Assessing Catecholamine Treatment Initiation Options: Norepinephrine vs Dopamine for Cardiogenic Shock

Not Yet Recruiting
NCT06508359Not Applicable

Norepinephrine and Phenylephrine for Spinal Anesthesia-induced Hypotension.

Completed
NCT06498076Not Applicable

Management of Postspinal Anesthesia Hypotension During Elective Cesarean Section: Baby Norepinephrine Versus Ephedrine

Completed
NCT07418541Not Applicable

Early Co-Administration of Crystalloid Fluid and Norepinephrine for Preventing Acute Kidney Injury in Septic Shock

Not Yet Recruiting
NCT05179499Phase 3

Early Vasopressors in Sepsis

Recruiting
NCT07322133Phase 4

Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE)

Recruiting
NCT06344442Phase 3

Low-dose Arginine-vasopressin Supplementation on Post-transplant Acute Kidney Injury After Liver Transplantation (AVENIR Trial)

Recruiting
NCT07327320Phase 4

Norepinephrine vs. Phenylephrine for Hypotension in Low-Dose Spinal Anesthesia for Cesarean Delivery

Completed
NCT02118467Phase 4

Vasoactive Drugs in Intensive Care Unit

Recruiting
NCT06053398Early Phase 1

Vasopressor Outcomes in Spine Surgery

Completed
NCT06921473Phase 4

Effect of Ephedrine vs. Norepinephrine on Prevention of Fetal Acidosis During Cesarean Section Under Spinal Anesthesia

Completed
NCT05568160Phase 3

Evaluation of the Superiority of VAsopressin Versus NOradrenaline in the Management of Patients at Risk of Kidney Failure Undergoing Cardiac Surgery With Extracorporeal Circulation

Active Not Recruiting
NCT04789330Phase 4

Norepinephrine vs Phenylephrine During General Anesthesia

Completed

Drug Details

Intervention Type
DRUG
Total Trials
145